The British Journal of Clinical Pharmacy
– Volume 2, Issue 1 January 2010

EDITOR'S COMMENTS
  A focus on quality
   
NEWS
  Generic substitution proposals published
  Varenicline is safe and effective for smoking cessation in CVD
  Effectiveness of ‘pharmaceutical care’ model questioned

ADVERTISEMENTS


   
NEWS FEATURE
  Pharmacists’ priorities for 2010
This year is likely to be a challenging one for the pharmacy profession. Shona Kirk asks some leading pharmacists to outline their key priorities and challenges for 2010.
   
CLINICAL UPDATE
  Use of bivalirudin for acute coronary syndromes
Bivalirudin has been newly licensed for use in patients undergoing percutaneous coronary intervention who have ST-segment elevation myocardial infarction (STEMI). It is also licensed for patients with unstable angina and non-STEMI. This article describes its use. By Mojgan Sani.
 
COMMENTARY
  Interpreting the ACUITY trial
The ACUITY trial concluded that anticoagulation with the thrombin inhibitor bivalirudin was as effective as current treatments in patients with acute coronary syndromes. However, the results should be interpreted with caution, say Anthony Grosso and Pritesh Bodalia.
   
  How pharmacy can improve medicines use in care homes
This month the Department of Health called for immediate action to improve the safety of medicines use in care homes. This follows a recent study highlighting a high rate of medication errors among care home residents. This article outlines what we have learnt from that study and recommends how pharmacists can improve the use of medicines in this vulnerable population. By David Alldred, Nick Barber, Claire Standage and David Raynor.
   
OPINION
  Why our professional agenda must be clinically focused
A fundamental change is needed for pharmacists to get the best clinical value out of medicines. This requires pharmacists in all sectors of the profession to work together in a clinical approach, says David Branford.
   
PRESCRIBER’S CORNER
  Managing dyspeptic symptoms
Prescriber’s Corner describes situations encountered by pharmacist prescribers and invites you to consider clinical decisions about the patient. In this case, you are managing a patient who is suffering from gastrointestinal discomfort after meals. By Andrew Husband and Anne-Marie Bailey.
   
EDUCATION
  Training doctors to use electronic prescribing information sources
An electronic learning package has been developed by pharmacists at the Chelsea and Westminster Hospital NHS Foundation Trust to consolidate e-prescribing training and introduce information sources that are helpful to junior doctors. This article describes its implementation. By Barry Jubraj, David Henry, India Hardy and Neil McCall-Peat
   
PROFILE
  Diversity of a consultant oncology pharmacist’s role
Steve Williamson is a consultant pharmacist for cancer services at Northumbria Healthcare NHS Foundation Trust and the North of England Cancer Network, and is also an independent prescriber. This article describes his diverse role. By Shona Kirk.
   
SHARING PRACTICE
  Improving medication management services
A pharmacist-led medication management clinic (MMC) that supports women’s healthcare in mid-life has been established in the North West London Hospitals NHS Trust. This article describes results from an audit showing that the clinic supports continuity of care. By Chhaya Prasannan-Nair, Nuttan Tanna and Joan Pitkin.
   
MEETINGS
  Pharmacists reduce drug errors in the emergency department
Drug safety, system design and maintaining quality were issues discussed at this year’s American Society of Health-System Pharmacists midyear clinical meeting. Hannah Pike reports.
   
LAST WORD
  Why one professional body is not sufficient for pharmacy
As pharmacists become increasing specialised, their professional support requirements are changing. In this article Philip Brown draws parallels with the medical profession to explain why pharmacists need more than one professional body.
 
 
The British Journal of Clinical Pharmacy is an editorially independent publication.
Copyright of the The British Journal of Clinical Pharmacy. No reproduction in any format is allowed unless permission is granted by the publisher.